018680 Stock Chart & Stats
₩1988.00
-₩112.00(-5.33%)
―
--
Day’s Range― - ―
52-Week Range₩1,913.00 - ₩3,400.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.31K
Market Cap
₩24.48B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)31.9
Beta-0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,659,319
10 Day Avg. Volume6,896
30 Day Avg. Volume8,314
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
018680 FAQ
What was Seoul Pharma Co., Ltd.’s price range in the past 12 months?
Seoul Pharma Co., Ltd. lowest stock price was ₩1913.00 and its highest was ₩3400.00 in the past 12 months.
What is Seoul Pharma Co., Ltd.’s market cap?
Seoul Pharma Co., Ltd.’s market cap is ₩24.48B.
When is Seoul Pharma Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Seoul Pharma Co., Ltd.’s earnings last quarter?
Seoul Pharma Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩16.464 earnings per share for the quarter, missing the consensus estimate of N/A by -₩16.464.
Is Seoul Pharma Co., Ltd. overvalued?
According to Wall Street analysts Seoul Pharma Co., Ltd.’s price is currently Undervalued.
Does Seoul Pharma Co., Ltd. pay dividends?
Seoul Pharma Co., Ltd. does not currently pay dividends.
What is Seoul Pharma Co., Ltd.’s EPS estimate?
Seoul Pharma Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seoul Pharma Co., Ltd. have?
Seoul Pharma Co., Ltd. has 11,659,319 shares outstanding.
What happened to Seoul Pharma Co., Ltd.’s price movement after its last earnings report?
Seoul Pharma Co., Ltd. reported an EPS of -₩16.464 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.189%.
Which hedge fund is a major shareholder of Seoul Pharma Co., Ltd.?
Currently, no hedge funds are holding shares in KR:018680
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dongsung Pharmaceutical Co., Ltd.
―
Daesung Microbiological Laboratories Co., Ltd.
―
Kyungnam Pharm Co., Ltd.
―
BIO PORT KOREA, INC.
―
Finemedix Co., Ltd.
―